Active specific immunotherapiy using attenuated autologous tumor cells in malignant melanoma (2000)
Fonte: Program Proceedings American Society of Clinical Oncology. Nome do evento: Thirty-Sixty Annual Meeting of the American Society of Clinical Oncology. Unidade: FM
Assunto: ONCOLOGIA
ABNT
SILVA, D. C et al. Active specific immunotherapiy using attenuated autologous tumor cells in malignant melanoma. Program Proceedings American Society of Clinical Oncology. New Orleans: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 17 ago. 2024. , 2000APA
Silva, D. C., Feher, O., Nomizo, R., Gross, J. L., Neves, R. I., & Brentani, M. M. (2000). Active specific immunotherapiy using attenuated autologous tumor cells in malignant melanoma. Program Proceedings American Society of Clinical Oncology. New Orleans: Faculdade de Medicina, Universidade de São Paulo.NLM
Silva DC, Feher O, Nomizo R, Gross JL, Neves RI, Brentani MM. Active specific immunotherapiy using attenuated autologous tumor cells in malignant melanoma. Program Proceedings American Society of Clinical Oncology. 2000 ; 19 463a.[citado 2024 ago. 17 ]Vancouver
Silva DC, Feher O, Nomizo R, Gross JL, Neves RI, Brentani MM. Active specific immunotherapiy using attenuated autologous tumor cells in malignant melanoma. Program Proceedings American Society of Clinical Oncology. 2000 ; 19 463a.[citado 2024 ago. 17 ]